NFG
IBB icon

Next Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

Next Financial Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1.81M Buy
11,848
+1,771
+18% +$274K 0.12% 192
2021
Q3 		$1.63M Sell
10,077
-1,267
-11% -$213K 0.13% 179
2021
Q2 		$1.86M Sell
11,344
-704
-6% -$108K 0.15% 155
2021
Q1 		$1.81M Sell
12,048
-4,536
-27% -$720K 0.16% 140
2020
Q4 		$2.51M Sell
16,584
-3,400
-17% -$486K 0.24% 100
2020
Q3 		$2.71M Sell
19,984
-136
-0.7% -$18.4K 0.29% 89
2020
Q2 		$2.75M Buy
20,120
+7,285
+57% +$929K 0.32% 79
2020
Q1 		$1.38M Buy
12,835
+633
+5% +$72.9K 0.18% 123
2019
Q4 		$1.47M Buy
12,202
+1,390
+13% +$155K 0.15% 152
2019
Q3 		$1.08M Sell
10,812
-341
-3% -$35.7K 0.12% 223
2019
Q2 		$1.22M Buy
11,153
+6,431
+136% +$684K 0.13% 195
2019
Q1 		$528K Sell
4,722
-1,589
-25% -$174K 0.13% 106
2018
Q4 		$609K Buy
6,311
+3,239
+105% +$344K 0.13% 186
2018
Q3 		$375K Sell
3,072
-2,780
-48% -$327K 0.17% 123
2018
Q2 		$643K Sell
5,852
-2,840
-33% -$304K 0.25% 104
2018
Q1 		$928K Buy
8,692
+3,666
+73% +$406K 0.2% 131
2017
Q4 		$537K Sell
5,026
-377
-7% -$40.3K 0.23% 125
2017
Q3 		$606K Sell
5,403
-1,209
-18% -$129K 0.17% 138
2017
Q2 		$683K Sell
6,612
-474
-7% -$46.7K 0.17% 144
2017
Q1 		$703K Sell
7,086
-5,292
-43% -$507K 0.2% 117
2016
Q4 		$1.09M Buy
12,378
+3,720
+43% +$339K 0.19% 121
2016
Q3 		$835K Buy
8,658
+3,366
+64% +$320K 0.15% 152
2016
Q2 		$453K Buy
5,292
+105
+2% +$9.42K 0.14% 152
2016
Q1 		$450K Buy
5,187
+141
+3% +$12.6K 0.16% 143
2015
Q4 		$569K Sell
5,046
-126
-2% -$13.7K 0.21% 110
2015
Q3 		$522K Buy
5,172
+687
+15% +$82.4K 0.19% 119
2015
Q2 		$551K Sell
4,485
-1,272
-22% -$152K 0.19% 122
2015
Q1 		$659K Buy
5,757
+42
+0.7% +$4.63K 0.21% 121
2014
Q4 		$578K Sell
5,715
-5,634
-50% -$548K 0.19% 126
2014
Q3 		$1.03M Buy
11,349
+11,340
+126,000% +$995K 0.21% 115
2014
Q2 		$1K Buy
+9
New +$709 ﹤0.01% 1152

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Next Financial Group's IBB Position: Q4 2021 in Review

Next Financial Group increased its iShares Biotechnology ETF (IBB) stake by 18% in Q4 2021, buying an estimated $274K and bringing the position to 11,848 shares worth $1.81M. The position accounts for 0.12% of the portfolio, ranked #192.

Next Financial Group first reported a position in IBB in Q2 2014 and has held it in 31 quarters since. The position peaked at $2.75M in Q2 2020. 962 funds tracked by Wall St. Rank hold IBB as of Q4 2021.

  • Next Financial Group held 11,848 shares of iShares Biotechnology ETF worth $1.81M as of Q4 2021.
  • Next Financial Group bought 1,771 iShares Biotechnology ETF shares in Q4 2021, an estimated $274K.
  • iShares Biotechnology ETF made up 0.12% of Next Financial Group's portfolio in Q4 2021, its #192 holding.
  • Next Financial Group first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 31 quarters since.
  • Next Financial Group's iShares Biotechnology ETF position peaked at $2.75M in Q2 2020.
  • 962 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.